4-Chloro-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine, 95.0%, 1g

(3R,4R)-1-(tert-Butoxycarbonyl)-4-methylpyrrolidine-3-carboxylic acid, 95.0%, 100mg

4-(2-oxopyrrolidin-1-yl)pyridine-2-carboxylic acid, >95%, 1g

3,4,8,9,10,11-hexahydro-2H-cyclohepta[3,4]pyrrolo[1,2-a]pyrazin-1(7H)-one, 98%, 500mg

1-((2,5-dichlorophenyl)sulfonyl)-5-methylthio-1,2,4-triazole-3-ylamine, 98%, 10g

2,5-Diiodobenzotrifluoride, 5g

1H,3H-Furo[3,4-c]furan, 1-(3,4-dimethoxyphenyl)tetrahydro-4-(3,4,5-trimethoxyphenyl)-, (1S,3aR,4S,6aR)-, 98%, 50mg

2-Methoxy-5-methylnicotinaldehyde, 95+%, 250mg

2-(4-isopropylpiperazine-1-carbonyl)benzoic acid, 95.0%, 500mg

3-(CHLOROMETHYL)-5-METHYLPYRIDAZINE HCL, 95.0%, 250mg

Benzo[c][1,2,5]oxadiazole-5-carbonitrile, 95.0%, 250mg

Diethylenetriamine, min. 98%, for synthesis, 100 ml, glass packaging

Accessories holders Stainless steel holder sideways, 1 piece